Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Travis S Johnson

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Nature Communications|May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myelomaTravis S Johnson, Parvathi Sudha, Enze Liu, et al.
Genome Medicine|February 2, 2022
Diagnostic Evidence GAuge of Single cells (DEGAS): a flexible deep transfer learning framework for prioritizing cells in relation to diseaseTravis S Johnson, Christina Y Yu, Zhi Huang, et al.
Research Square|June 30, 2025
An induced pluripotent stem cell model of Schwann cell differentiation reveals NF2- related gene regulatory networksOlivia Lazaro, Sihong Li, William Carter, et al.
Cancer Immunology Research|May 8, 2025
Identification of the distinct immune microenvironment features associated with progression following high dose melphalan and autologous stem cell transplant in multiple myelomaParvathi Sudha, Travis S Johnson, Habib Hamidi, et al.
Cell Death & Disease|February 12, 2026
RIPK1 regulates β-cell fate via actions on gene expression and kinase signaling in a mouse model of β-cell self-reactivityChristopher J Contreras, Noyonika Mukherjee, Arianna Harris-Kawano, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Target deconvolution of an insulin hypersecretion-inducer acting through VDAC1 with a distinct transcriptomic signature in beta-cellsGitanjali Roy, Andrea Ordóñez, Derk D Binns, et al.
Cell Reports|June 13, 2025
VDAC1 is a target for pharmacologically induced insulin hypersecretion in β cellsGitanjali Roy, Andrea Ordóñez, Derk D Binns, et al.
Journal of Medicinal Chemistry|April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Nature Communications|May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myelomaTravis S Johnson, Parvathi Sudha, Enze Liu, et al.
Genome Medicine|February 2, 2022
Diagnostic Evidence GAuge of Single cells (DEGAS): a flexible deep transfer learning framework for prioritizing cells in relation to diseaseTravis S Johnson, Christina Y Yu, Zhi Huang, et al.
Research Square|June 30, 2025
An induced pluripotent stem cell model of Schwann cell differentiation reveals NF2- related gene regulatory networksOlivia Lazaro, Sihong Li, William Carter, et al.
Cancer Immunology Research|May 8, 2025
Identification of the distinct immune microenvironment features associated with progression following high dose melphalan and autologous stem cell transplant in multiple myelomaParvathi Sudha, Travis S Johnson, Habib Hamidi, et al.
Cell Death & Disease|February 12, 2026
RIPK1 regulates β-cell fate via actions on gene expression and kinase signaling in a mouse model of β-cell self-reactivityChristopher J Contreras, Noyonika Mukherjee, Arianna Harris-Kawano, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Target deconvolution of an insulin hypersecretion-inducer acting through VDAC1 with a distinct transcriptomic signature in beta-cellsGitanjali Roy, Andrea Ordóñez, Derk D Binns, et al.
Cell Reports|June 13, 2025
VDAC1 is a target for pharmacologically induced insulin hypersecretion in β cellsGitanjali Roy, Andrea Ordóñez, Derk D Binns, et al.
Journal of Medicinal Chemistry|April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Pageof 5